MedPath
FDA Approval

Raloxifene Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 4, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Raloxifene(60 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

American Health Packaging

American Health Packaging

929561009

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Raloxifene Hydrochloride

Product Details

NDC Product Code
60687-266
Application Number
ANDA090842
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 4, 2022
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OHClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82Class: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6Class: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
Code: 4F86W47BR6Class: ACTIBQuantity: 60 mg in 1 1
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
POLOXAMER 407Inactive
Code: TUF2IVW3M2Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
© Copyright 2025. All Rights Reserved by MedPath